RankingsPricing
  1. JP-listed companies
  2. EnBio Holdings,Inc
  3. Financials
  4. Cash and cash equivalents

EnBio Holdings,IncJP:6092

Market cap
¥4.8B
P/E ratio
6.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 20253,293-8.63%
Mar 31, 20243,604+27.41%
Mar 31, 20232,829+19.27%
Mar 31, 20222,372+17.68%
Mar 31, 20212,015-32.40%
Mar 31, 20202,981+27.29%
Mar 31, 20192,342-33.38%
Mar 31, 20183,515+119.70%
Mar 31, 20171,600-18.07%
Mar 31, 20161,953+83.52%
Mar 31, 20151,064

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)